Millennium Management’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
Other funds holding TARS
Millennium Management's TARS Position: Q3 2026 in Review
Millennium Management reduced its Tarsus Pharmaceuticals (TARS) stake by 23% in Q3 2026, selling an estimated $23.2M and leaving 1,093,868 shares worth $85.5M. The position accounts for 0.03% of the portfolio, ranked #601.
Millennium Management first reported a position in TARS in Q4 2020 and has held it in 17 quarters since. The position peaked at $89.8M in Q2 2026. 255 funds tracked by Wall St. Rank hold TARS as of Q3 2026.
- Millennium Management held 1,093,868 shares of Tarsus Pharmaceuticals worth $85.5M as of Q3 2026.
- Millennium Management sold 333,256 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $23.2M.
- Tarsus Pharmaceuticals made up 0.03% of Millennium Management's portfolio in Q3 2026, its #601 holding.
- Millennium Management first reported a position in Tarsus Pharmaceuticals in Q4 2020 and has held it in 17 quarters since.
- Millennium Management's Tarsus Pharmaceuticals position peaked at $89.8M in Q2 2026.
- 255 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.